These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 6461005)
1. Identification of a variant of mucolipidosis III (pseudo-Hurler polydystrophy): a catalytically active N-acetylglucosaminylphosphotransferase that fails to phosphorylate lysosomal enzymes. Varki AP; Reitman ML; Kornfeld S Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7773-7. PubMed ID: 6461005 [TBL] [Abstract][Full Text] [Related]
2. Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity. Reitman ML; Varki A; Kornfeld S J Clin Invest; 1981 May; 67(5):1574-9. PubMed ID: 6262380 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the mutant N-acetylglucosaminylphosphotransferase in I-cell disease and pseudo-Hurler polydystrophy: complementation analysis and kinetic studies. Ben-Yoseph Y; Pack BA; Mitchell DA; Elwell DG; Potier M; Melançon SB; Nadler HL Enzyme; 1986; 35(2):106-16. PubMed ID: 3017692 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of lysosomal enzymes in fibroblasts. Marked deficiency of N-acetylglucosamine-1-phosphotransferase in fibroblasts of patients with mucolipidosis III. Waheed A; Hasilik A; Cantz M; von Figura K Hoppe Seylers Z Physiol Chem; 1982 Feb; 363(2):169-78. PubMed ID: 6460679 [TBL] [Abstract][Full Text] [Related]
5. I-cell disease and pseudo-Hurler polydystrophy: heterozygote detection and characteristics of the altered N-acetyl-glucosamine-phosphotransferase in genetic variants. Mueller OT; Little LE; Miller AL; Lozzio CB; Shows TB Clin Chim Acta; 1985 Aug; 150(3):175-83. PubMed ID: 2998644 [TBL] [Abstract][Full Text] [Related]
6. Demonstration of the heterozygous state for I-cell disease and pseudo-Hurler polydystrophy by assay of N-acetylglucosaminylphosphotransferase in white blood cells and fibroblasts. Varki A; Reitman ML; Vannier A; Kornfeld S; Grubb JH; Sly WS Am J Hum Genet; 1982 Sep; 34(5):717-29. PubMed ID: 6289658 [TBL] [Abstract][Full Text] [Related]
7. Altered molecular size of N-acetylglucosamine 1-phosphotransferase in I-cell disease and pseudo-Hurler polydystrophy. Ben-Yoseph Y; Potier M; Mitchell DA; Pack BA; Melançon SB; Nadler HL Biochem J; 1987 Dec; 248(3):697-701. PubMed ID: 2829837 [TBL] [Abstract][Full Text] [Related]
9. Steps in the phosphorylation of the high mannose oligosaccharides of lysosomal enzymes. Kornfeld S; Reitman ML; Varki A; Goldberg D; Gabel CA Ciba Found Symp; 1982; (92):138-56. PubMed ID: 6295719 [TBL] [Abstract][Full Text] [Related]
10. Mucolipidoses II and III variants with normal N-acetylglucosamine 1-phosphotransferase activity toward alpha-methylmannoside are due to nonallelic mutations. Ben-Yoseph Y; Mitchell DA; Yager RM; Wei JT; Chen TH; Shih LY Am J Hum Genet; 1992 Jan; 50(1):137-44. PubMed ID: 1309624 [TBL] [Abstract][Full Text] [Related]
11. Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta -subunits precursor gene. Kudo M; Brem MS; Canfield WM Am J Hum Genet; 2006 Mar; 78(3):451-63. PubMed ID: 16465621 [TBL] [Abstract][Full Text] [Related]
12. Lysosomal enzyme phosphorylation in human fibroblasts. Kinetic parameters offer a biochemical rationale for two distinct defects in the uridine diphospho-N-acetylglucosamine:lysosomal enzyme precursor N-acetylglucosamine-1-phosphotransferase. Lang L; Takahashi T; Tang J; Kornfeld S J Clin Invest; 1985 Dec; 76(6):2191-5. PubMed ID: 3001146 [TBL] [Abstract][Full Text] [Related]
14. The DMAP interaction domain of UDP-GlcNAc:lysosomal enzyme N-acetylglucosamine-1-phosphotransferase is a substrate recognition module. Qian Y; Flanagan-Steet H; van Meel E; Steet R; Kornfeld SA Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10246-51. PubMed ID: 23733939 [TBL] [Abstract][Full Text] [Related]
15. Mucolipidosis II and III. The genetic relationships between two disorders of lysosomal enzyme biosynthesis. Mueller OT; Honey NK; Little LE; Miller AL; Shows TB J Clin Invest; 1983 Sep; 72(3):1016-23. PubMed ID: 6309902 [TBL] [Abstract][Full Text] [Related]
16. GNPTAB c.2404C > T nonsense mutation in a patient with mucolipidosis III alpha/beta: a case report. Ho CC; Tsung LL; Liu KT; Poon WT BMC Med Genet; 2018 Sep; 19(1):162. PubMed ID: 30208878 [TBL] [Abstract][Full Text] [Related]
17. Analysis of mucolipidosis II/III GNPTAB missense mutations identifies domains of UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase involved in catalytic function and lysosomal enzyme recognition. Qian Y; van Meel E; Flanagan-Steet H; Yox A; Steet R; Kornfeld S J Biol Chem; 2015 Jan; 290(5):3045-56. PubMed ID: 25505245 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of N-acetylglucosamine 1-phosphotransferase within mucolipidosis III. Little LE; Mueller OT; Honey NK; Shows TB; Miller AL J Biol Chem; 1986 Jan; 261(2):733-8. PubMed ID: 3001079 [TBL] [Abstract][Full Text] [Related]
19. [I-cell disease and pseudo-Hurler polydystrophy]. Owada M Nihon Rinsho; 1995 Dec; 53(12):3028-34. PubMed ID: 8577054 [TBL] [Abstract][Full Text] [Related]
20. Biosynthesis, processing, and secretion of alpha-L-fucosidase in lymphoid cells from patients with I-cell disease and pseudo-Hurler polydystrophy. DiCioccio RA; Miller AL Glycobiology; 1991 Dec; 1(6):595-604. PubMed ID: 1822239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]